HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.

Latest From David Ridley

LanesHealth Alert To Cognitive Health And Naturals Trends With UK Supplement Launches

LanesHealth's UK supplement brands Pro Plus and Gopo get on-trend line extenstions in the areas of cognitive health and natural medicinal alternatives. 

United Kingdom Wellness

Numan Adds Automation To Its Digital Consumer Health Offer With Vi-Health Acquisition

UK men's health platform Numan continues its mission of disrupting the consumer health industry with its acquisition of Sweden’s Vi-Health technology – a Class I medical device that includes an artificial intelligence-powered symptom checker, as well as advanced e-consultation and workflow automation tools.

United Kingdom Sweden

The Future Of Europe's CBD Market Lies With Big Pharma And OTC Pathway

The "shakers and movers" in the European cannabidiol market in the next two to three years will be big pharma, says Irish synthetic CBD specialist Chanelle McCoy Health. With its purported health benefits, CBD will also need to go the way of OTC drugs, with medicinal claims supported by clinical trials, the firm predicts. 

Europe United Kingdom

Starpharma’s COVID Nasal Spray Launched In UK

Australia's Starpharma has launched in the UK its Viraleze antiviral COVID-19 nasal spray. On pack messaging states that the product "inactivates respiratory viruses, including >99.9% of coronavirus SARS-CoV-2."

United Kingdom Health

Next Generation OTC Painkillers And Cough Syrup On Cards For German Switch Committee

Rx-to-OTC switches of the painkillers dexibuprofen and single-pill combinations of ibuprofen and paracetamol as well as the cough medicine levodropropizine, all for oral use, will be considered at the next German Expert Committee for Prescription meeting on 13 July.

Germany Health

Podcast: The Week In European Consumer Health Industry News, 29 March 2021

HBW editors Tom Gallen and David Ridley discuss the big issues in the European consumer health market from the past week. In this edition, they delve into CBD, probiotics, and GSK's sustainability plans.

Europe Health
See All
UsernamePublicRestriction

Register